Trending stocks
$PEL  
$SRF  
$INFY  

Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited, together with its subsidiaries, manufactures and sells branded and unbranded generic pharmaceutical products in India and internationally.

Industry: Pharmaceuticals

Ticker Exchange ISIN Name
$TORNTPHARM BSE INE685A01028 Code: 500420
$TORNTPHARM NSE INE685A01028

Twit about TORNTPHARM stock

Use $ before stock tickers (like $ABB), # before hashtags (like #bearish)

Latest twits on Torrent Pharmaceuticals (TORNTPHARM)

4

Rajesh Khattar 03:20 PM 23-04-2015

$TORNTPHARM $ARVINDREM you can see this pharma stocks correction after 2y rally in Arvind Remedies already

4

Rajesh Khattar 03:18 PM 23-04-2015

$TORNTPHARM Pharma shares may correct 20-30% downward after the big rally for the last 2 years #bearish

+1 (1)

4

Aaarti Ambani 03:15 PM 23-04-2015

$TORNTPHARM Oversold as of now, can show 2-4 percent bounce back #bullish

Akshay Bhardwaj 09:27 PM 17-02-2015

Record volume yesterday in $TORNTPHARM since May 2014 - 332275 shares changed hands, somebody is accumulating a position and putting a high bet on the stock.

+1 (1)

Akshay Bhardwaj 08:20 PM 17-02-2015

$TORNTPHARM why everybody is so negative on the stock?

+1 (1)

4

Rajesh Khattar 12:49 PM 10-02-2015

$TORNTPHARM I believe the stock should correct at least to 1000 level

Meera Sharma 01:36 PM 07-02-2015

$TORNTPHARM on Friday (February 6) the stock broke 1100 support level so further downside to September 2014 plato of 850-875 is possible

4

Aaarti Ambani 02:54 PM 04-02-2015

New research report on $TORNTPHARM with #buy rating. They treat Q3 2014 as "In-line quarter" and believe in margin expansion. bsmedia.business-standard...1100.pdf

5

Nita Bhardwaj 04:05 PM 31-01-2015

$TORNTPHARM yes, revenue declined QoQ but such events happened on the way of Torrent growth - look at Q4 2012, Q4 2011, Q4 2010, Q2 2009. And it always rebounded to continue 19-30% revenue growth I mentioned before. So don't panic and #hold If the price goes lower - it will be a good buying opportunity!

+1 (1)

4

Rajesh Khattar 09:51 PM 30-01-2015

$TORNTPHARM results are quite disappointing - revenue and gross profit declined. And the revenue in Q1-Q3 2014 is still below that of in Q4 2013. It looks like it's not a growing company any more... #sell while the price is still good

4

Rajesh Khattar 09:21 PM 30-01-2015

$TORNTPHARM Press-release www.torrentpharma.com/med...?mid=148 and financial statements www.torrentpharma.com/pdf...inal.pdf

4

Rajesh Khattar 09:20 PM 30-01-2015

$TORNTPHARM Torrent Pharma announces Q3 FY 14-15 results
• For Q314-15 revenues were at Rs. 1,168 crores, up by 15% from Rs. 1,015 crores during the same period last year.
• EBITDA for Q314-15 was at Rs. 305 crores up by 36% from Rs. 225 crores during the same period last year.
• PAT for Q314-15 was at Rs. 167 crores up by 6% compared to Rs. 158 crores during the same period last year.
• Company declared an interim dividend of 100% (Rs. 5/- per share).

5

Nita Bhardwaj 12:14 PM 15-01-2015

$TORNTPHARM the company was growing 19-30% in 2012-2014FY and is forecated to grow 15-20% in 2015-2017FY. EBITDA margin was expanding and have reached 27%. It's expected to drop a bit to 25%. And for this growth minus EBITDA decrease you pay 19x EV/EBITDA - for me it's a fair price and I don't expect much growth in the first half of 2015.

+1 (1)

5

Nita Bhardwaj 07:15 PM 09-01-2015

$TORNTPHARM But I expect 7-10% growth in the 2nd half 2015 in line with revenue growth. #hold

+1 (1)

4

Aaarti Ambani 08:05 PM 29-11-2014

$TORNTPHARM @Akshay-Bhardwaj @Rajesh-Khattar I would add that their revenue base is international and well diversified (29% US, 35% Europe, 20% Brasil) so that's why it had steady growth which is not supposed to interrupt. Also, pharma industry is growing well in developed countries - population is aging and wants more drugs unfortunatelly... Torrent is a beneficiary of this process

Akshay Bhardwaj 03:12 PM 29-11-2014

$TORNTPHARM @Rajesh-Khattar this company has a clear long term growth strategy which will keep delivering Revenue and EBITDA growth in 2015. The stock will continue to grow in 2015 - you will see!

4

Rajesh Khattar 04:42 PM 28-11-2014

$TORNTPHARM is growing since 2015 without major interruption... I believe 2015 will be year for at least a temporary break #hold